======= RNASEH2C =======
== Gene Information ==
* **Official Symbol**: RNASEH2C
* **Official Name**: ribonuclease H2 subunit C
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=84153|84153]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q8TDP1|Q8TDP1]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=RNASEH2C&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RNASEH2C|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/610330|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a ribonuclease H subunit that can cleave ribonucleotides from RNA:DNA duplexes. Mutations in this gene cause Aicardi-Goutieres syndrome-3, a disease that causes severe neurologic dysfunction. A pseudogene for this gene has been identified on chromosome Y, near the sex determining region Y (SRY) gene. [provided by RefSeq, Jul 2008].
* **UniProt Summary**: Non catalytic subunit of RNase H2, an endonuclease that specifically degrades the RNA of RNA:DNA hybrids. Participates in DNA replication, possibly by mediating the removal of lagging- strand Okazaki fragment RNA primers during DNA replication. Mediates the excision of single ribonucleotides from DNA:RNA duplexes. {ECO:0000269|PubMed:16845400, ECO:0000269|PubMed:21177858}.
|RNase H2 suC|
|ribonuclease H2 complex|
|RNA catabolic process|
|nucleobase-containing compound catabolic process|
|heterocycle catabolic process|
|cellular nitrogen compound catabolic process|
|aromatic compound catabolic process|
|organic cyclic compound catabolic process|
|cellular macromolecule catabolic process|
|macromolecule catabolic process|
|RNA metabolic process|
|organic substance catabolic process|
|cellular catabolic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp299|Talazoparib 0.006μM R06 exp299]]|-2.14|
|[[:results:exp295|Pyronaridine 1μM R06 exp295]]|1.72|
|[[:results:exp505|ML-792 0.2μM R08 exp505]]|1.82|
^Gene^Correlation^
|[[:human genes:r:rnaseh2a|RNASEH2A]]|0.512|
|[[:human genes:r:rnaseh2b|RNASEH2B]]|0.402|
Global Fraction of Cell Lines Where Essential: 34/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|1/28|
|bone|2/26|
|breast|2/33|
|central nervous system|3/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|1/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|3/21|
|liver|0/20|
|lung|3/75|
|lymphocyte|1/16|
|ovary|1/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|4/22|
|urinary tract|4/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 4057
* **Expression level (log2 read counts)**: 5.74
{{:chemogenomics:nalm6 dist.png?nolink |}}